Keeping Current on Evolving Approaches in the Care of Hidradenitis Suppurativa

Saturday, November 15, 2025

2:00 PM – 3:00 PM PT simulcast
3:00 PM – 4:00 PM MT
4:00 PM – 5:00 PM CT
5:00 PM – 6:00 PM ET

EARN 1.0 CME/CNE/AAPA CREDITS!

Program Overview

This educational symposium is tailored for dermatology clinicians to enhance their expertise in diagnosing and managing of hidradenitis suppurativa (HS). The program will review evidence-based best practices and clinical strategies for early HS diagnosis, emphasizing the transformative role of biologic agents in treatment. It will also explore the practical use of these agents, focusing on individualizing therapy by balancing efficacy, safety, and patient-specific factors.

Target Audience

This educational activity is specifically designed for dermatology NPs and PAs, and dermatologists who care for patients with hidradenitis suppurativa.

Learning Objectives

Upon the completion of this program, attendees should be able to:

Facilitate a timely and accurate diagnosis of HS using evidence-based diagnostic criteria
Assess the mechanism of action of new and emerging biologic agents for HS in the context of the underlying pathophysiology of the disease
Interpret efficacy and safety data for new and emerging biologic agents for the treatment of HS
Develop comprehensive treatment plans in conjunction with patients and multidisciplinary colleagues to address HS and associated comorbidities

Joint Accreditation Statement

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Nurses (ANCC) Credit Designation

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

AAPA Credit Designation Statement – Live

Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ACCME INNOVATION PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure of Relevant Financial Relationships

Faculty Member	Disclosures
Laura Bush, DMSc, PA-C, DFAAPA	Consulting Fees: Amgen, Arcutis Biotherapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant Sciences, Janssen Pharmaceuticals, Johnson & Johnson, L’Oréal, Ortho Dermatologics, Sanofi, and Takeda Pharmaceuticals Speakers Bureaus: Boehringer Ingelheim, Ferndale Laboratories, and UCB Stock: Bristol Myers Squibb, and Vertex Pharmaceuticals

All relevant financial relationships have been mitigated.

Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
Shpetim Karandrea, PhD, Medical Director for Med Learning Group has nothing to disclose.
Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
A medical reviewer from CME Peer Review LLC, has nothing to disclose.
Jacquelyn Sandfort, Associate Program Manager for Med Learning Group, has nothing to disclose.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation

There are no fees for participating and receiving CE credit for this activity.  In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at info@medlearninggroup.com

Release date: November 15, 2025
Expiration date: November 15, 2025
Estimated time to completion: 1 hour